Digitala Vetenskapliga Arkivet

Planned maintenance
A system upgrade is planned for 17/11-2026, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Electrocardiographic abnormalities and NT-proBNP levels at long-term follow-up of patients with dyspnea after pulmonary embolism
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Section of Medicine.ORCID iD: 0000-0003-4574-9448
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Section of Medicine.ORCID iD: 0000-0002-5119-8411
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Section of Medicine.ORCID iD: 0000-0002-9279-2791
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Section of Medicine.
Show others and affiliations
2024 (English)In: Scandinavian Cardiovascular Journal, ISSN 1401-7431, E-ISSN 1651-2006, Vol. 58, no 1, article id 2373090Article in journal (Refereed) Published
Abstract [en]

Objectives: Electrocardiogram (ECG) and measurement of plasma brain natriuretic peptides (BNP) are established markers of right ventricular dysfunction (RVD) in the setting of acute pulmonary embolism (PE) but their value at long-term follow-up is largely unknown. The purpose of this prospective study was to determine the prevalence of ECG abnormalities, describe levels of N-terminal proBNP (NT-proBNP), and establish their association with dyspnea at long-term follow-up after PE.

Design: All Swedish patients diagnosed with acute PE in 2005 (n = 5793) were identified through the Swedish National Patient Registry. Surviving patients in 2007 (n = 3510) were invited to participate. Of these, 2105 subjects responded to a questionnaire about dyspnea and comorbidities. Subjects with dyspnea or risk factors for development of chronic thromboembolic pulmonary hypertension were included in the study in a secondary step, which involved collection of blood samples and ECG registration.

Results: Altogether 49.3% had a completely normal ECG. The remaining participants had a variety of abnormalities, 7.2% had atrial fibrillation/flutter (AF). ECG with any sign of RVD was found in 7.2% of subjects. Right bundle branch block was the most common RVD sign with a prevalence of 6.4%. An abnormal ECG was associated with dyspnea. AF was associated with dyspnea, whereas ECG signs of RVD were not. 61.2% of subjects had NT-proBNP levels above clinical cut-off (>125 ng/L). The degree of dyspnea did not associate independently with NT-proBNP levels.

Conclusions: We conclude that the value of ECG and NT-proBNP in long term follow-up after PE lies mostly in differential diagnostics.

Place, publisher, year, edition, pages
Taylor & Francis, 2024. Vol. 58, no 1, article id 2373090
Keywords [en]
CTEPD, CTEPH, ECG, NT-proBNP, post-PE syndrome, Pulmonary embolism, pulmonary hypertension
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:umu:diva-227879DOI: 10.1080/14017431.2024.2373090ISI: 001262358700001Scopus ID: 2-s2.0-85197477068OAI: oai:DiVA.org:umu-227879DiVA, id: diva2:1884198
Funder
Swedish Heart Lung FoundationRegion Västerbotten, ALF-VL-RV-548791Region Västerbotten, RV-841381Region Västerbotten, RV-967561Umeå UniversityAvailable from: 2024-07-15 Created: 2024-07-15 Last updated: 2026-11-02Bibliographically approved
In thesis
1. Pulmonary embolism beyond the acute phase: long-term symptoms, sequelae, and survival
Open this publication in new window or tab >>Pulmonary embolism beyond the acute phase: long-term symptoms, sequelae, and survival
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Lungemboli bortom det akuta skedet : långvariga symtom, följdtillstånd och överlevnad
Abstract [en]

Pulmonary embolism (PE) is a common cardiovascular disease associated with substantial short- and long-term morbidity. Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious but uncommon long-term complication, while a considerably larger proportion of patients experience persistent dyspnoea, exercise limitation, and impaired health status after PE. These manifestations, together with persistent cardiopulmonary abnormalities, are increasingly described within the concept of post-pulmonary embolism syndrome (PPES), which encompasses a heterogeneous spectrum ranging from functional impairment without an identified cardiopulmonary cause to chronic thromboembolic pulmonary disease (CTEPD) and CTEPH. However, the extent to which symptoms and abnormalities detected after PE represent consequences of the preceding embolic event, reflect underlying comorbidity, or constitute clinically meaningful pulmonary vascular disease remains uncertain. The overall aim of this thesis was to investigate long-term symptoms, cardiopulmonary abnormalities, and survival after PE, and to examine their relationships and clinical significance.

The first study examined the prevalence of dyspnoea in a nationwide cohort of Swedish PE survivors and compared them with a population-based control cohort. At a median of 3.4 years after PE, dyspnoea was markedly more common among PE survivors than among controls. The association between previous PE and dyspnoea remained significant after adjustment for age, sex, smoking habits, and multiple comorbidities, demonstrating a substantial long-term symptom burden associated with previous PE that was not explained by the measured comorbidities and other potential confounders.

The second study investigated electrocardiographic abnormalities and plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels among PE survivors selected because of dyspnoea or risk factors for chronic thromboembolic disease. Although abnormal electrocardiograms and elevated NT-proBNP levels were common, findings specifically suggestive of right ventricular dysfunction were infrequent. Neither electrocardiographic markers of right ventricular strain nor NT- proBNP levels were independently associated with dyspnoea severity. These findings suggest that the value of ECG and NT- proBNP in long-term follow-up after PE may primarily lie in differential diagnosis rather than in identifying a PE-specific cause of persistent dyspnoea.

The third study assessed whether dyspnoea at long-term follow-up after PE was associated with mortality. Although dyspnoea was associated with reduced survival in unadjusted analyses, it was not independently associated with mortality after adjustment for age, sex, smoking, and time-dependent comorbidities. Exploratory analyses suggested possible differences by sex and age, with dyspnoea being associated with increased mortality among men but not women, while age- stratified analyses showed no consistent pattern. No association between dyspnoea and mortality was observed in the population-based reference cohort.

The fourth study evaluated late perfusion defects assessed by ventilation–perfusion scintigraphy several years after the index PE. Perfusion defects were common and were associated with reduced survival in unadjusted analyses. However, after adjustment for age and comorbidities in inverse probability-weighted analyses, perfusion defects were not independently associated with long-term mortality. Furthermore, no association was observed between perfusion defects and dyspnoea severity. These findings suggest that the apparent prognostic impact of late perfusion defects largely reflects underlying patient characteristics rather than an independent effect.

In conclusion, dyspnoea and objective cardiopulmonary abnormalities are common at long-term follow-up after PE. However, the relationships between previous PE, persistent symptoms, objective abnormalities, and long-term prognosis are complex. Neither dyspnoea nor late perfusion defects were independently associated with mortality after accounting for age and comorbidities, and late perfusion defects were not associated with dyspnoea severity. Taken together, the findings do not support a simple model in which post-PE dyspnoea or late perfusion defects necessarily represent persistent PE- related disease. Future studies should better distinguish PE-related disease from comorbidity and other causes of long-term symptoms and abnormalities, and determine which findings identify clinically meaningful and potentially treatable disease. From a clinical perspective, persistent dyspnoea after PE should prompt an aetiologically open assessment in which potentially treatable pulmonary vascular disease is considered alongside cardiac and pulmonary comorbidity, deconditioning, and other causes of functional limitation. Similarly, late perfusion defects should not be interpreted in isolation as evidence that persistent thromboembolic disease explains a patient’s symptoms or prognosis.

Keywords: Pulmonary embolism, post-pulmonary embolism syndrome, NT-proBNP, ECG, chronic thromboembolic pulmonary disease, dyspnoea, mortality 

Place, publisher, year, edition, pages
Umeå: Umeå University, 2026. p. 95
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2453
Keywords
Pulmonary embolism, post-pulmonary embolism syndrome, NT-proBNP, ECG, chronic thromboembolic pulmonary disease, dyspnoea, mortality 
National Category
Respiratory Medicine and Allergy Cardiology and Cardiovascular Disease
Research subject
Internal Medicine
Identifiers
urn:nbn:se:umu:diva-261423 (URN)978-91-6850-159-8 (ISBN)978-91-6850-160-4 (ISBN)
Public defence
2026-11-27, Sal A1, Norrlands universitetssjukhus, byggnad 1D, vån 9, Umeå, 09:00 (Swedish)
Opponent
Supervisors
Projects
CTEPH-projektet
Note

Link to participate via Zoom: https://umu.zoom.us/j/62878331943?pwd=Tm0reC9LdDVrM1NoQjFjTS85YUZFZz09, password: 112233.

Available from: 2026-11-06 Created: 2026-10-30 Last updated: 2026-11-04Bibliographically approved

Open Access in DiVA

fulltext(1846 kB)218 downloads
File information
File name FULLTEXT01.pdfFile size 1846 kBChecksum SHA-512
7f542c5074a3796241ed137ea67e28348ce6d04412e649a14941b9309ffe8193db26e4bb27ede9f718f61f93064cab2228aa2c04308b3cfbb0932af6142210e2
Type fulltextMimetype application/pdf

Other links

Publisher's full textScopus

Search in DiVA

By author/editor
Nilsson, Lars T.Andersson, ThereseCarlberg, BoJohansson, LarsSöderberg, Stefan
By organisation
Section of Medicine
In the same journal
Scandinavian Cardiovascular Journal
Cardiology and Cardiovascular Disease

Search outside of DiVA

GoogleGoogle Scholar
Total: 220 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 553 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf